4th Quarter - Report

THE PERSONAL CARE PRODUCTS COUNCIL for PERSONAL CARE PRODUCTS COUNCIL

Firm
Client
Income
—
Expenses
$240,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trade issues-Executive Branch action concerning these issues

LobbyistCovered position, as disclosed
PAMELA G BAILEY —
JOHN A HURSON —
MICHAEL F THOMPSON —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); SENATE

Budget/Appropriations BUD

FY-09 Agriculture Appropriations (S.3289/ No Health Bill)- FDA Appropriations related to increased funding for the Office of Cosmetics and Colors within CFSAN

LobbyistCovered position, as disclosed
PAMELA G BAILEY —
JOHN A HURSON —
MICHAEL F THOMPSON —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE

Bills named: S. 3289 (110th)

Consumer Issues/Safety/Products CSP

Import safety- proposed legislation concerning this issue; Food safety legislation, FDA user fee- HR 3610, Food and Drug Import Safety Act of 2007; proposed legislation re these issues. Proposed legislation by Rep John Dingell (discussion draft of Food and Drug Globalization Act of 2008) related to the regulation of cosmetics.

LobbyistCovered position, as disclosed
PAMELA G BAILEY —
JOHN A HURSON —
MICHAEL F THOMPSON —

Contacted: SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 3610 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.